Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / January / Personalizing Corneal Cross-Linking
Cornea Opinions Research & Innovations

Personalizing Corneal Cross-Linking

How tailored approaches to CXL are transforming how we treat keratoconus and other corneal ectasias

By Emilio de Almeida Torres-Netto 1/12/2026 6 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders
Top Institutions in Ophthalmology - Corneal Cross-Linking

Leading institutions employ advanced clinical trials, biomechanical assessments, and translational research to refine CXL protocols, including novel riboflavin formulations, oxygen modulation, and UV irradiation techniques, enabling personalized treatment strategies.

  • #1

    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    UCSF is a leader in corneal biomechanics research and clinical innovation in CXL, with pioneering studies on epi-on protocols and personalized treatment approaches.

    Key Differentiators

    • Ophthalmology
    • Corneal Surgery
    • Clinical Research
  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Massachusetts Eye and Ear has extensive expertise in corneal ectatic diseases and has contributed to the development of customized CXL protocols integrating biomechanical and optical enhancements.

    Key Differentiators

    • Ophthalmology
    • Corneal Disease
    • Translational Research
  • #3

    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Bascom Palmer is renowned for its clinical expertise in keratoconus and CXL, with significant contributions to epi-on technique optimization and patient-specific treatment protocols.

    Key Differentiators

    • Ophthalmology
    • Corneal Surgery
    • Clinical Trials
  • #4

    University of Zurich, Department of Ophthalmology

    Zurich, Zurich

    The University of Zurich has contributed significantly to the biomechanical understanding of CXL and the development of precision-guided treatment protocols including oxygen modulation techniques.

    Key Differentiators

    • Ophthalmology
    • Corneal Research
    • Biomedical Engineering

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: